OptimizeRx Corporation Common Stock
OPRXStock
$6.65−48.50%52W
Market Cap$126.29M
P/E24.61x
Div yield—
Beta1.05
Price Chart
Favorite Metrics
Price vs S&P 500 (26W)-59.65%
Price vs S&P 500 (4W)23.14%
VGM Score55.71
Market Capitalization$126.29M
P/E Ratio (Annual)24.61x
Earnings Surprise History
Q1 260.14est. 0.00
Analyst Recommendations
Apr 2026
May 2026
Jun 2026
Jul 2026
4.15
4.15
4.15
4.25
Industry Peers — Business Services(119)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
OPRXOptimizeRx Corporation Common Stock | B | C | C | $6.65 |
| VVISA Inc. | D | C | B | $365.14 |
| MAMastercard Incorporated | D | B | B | $551.54 |
| UBERUber Technologies, Inc. | C | C | C | $74.04 |
| MELIMercado Libre, Inc | C | B | C | $1857.42 |
| ACNAccenture PLC | B | C | D | $144.61 |
| DASHDoorDash, Inc. Class A Common Stock | F | B | C | $186.36 |
| RELXRELX PLC | C | C | C | $34.02 |
| PYPLPayPal Holdings, Inc. Common Stock | B | C | B | $56.73 |
| EBAYeBay Inc | D | D | B | $110.91 |
| MSCIMSCI, Inc. | D | C | B | $637.24 |
About
OptimizeRx provides a cloud-based digital health messaging platform integrated with electronic health records that enables pharmaceutical companies to communicate directly with healthcare providers and patients. The platform supports medication adherence through real-time access to financial assistance, prior authorization, clinical information, and patient education. Its product suite includes Financial Messaging, Brand and Clinical Messaging, Brand Support, and Patient Engagement.